Breast Cancer Diagnostic Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Breast Cancer Diagnostic Market size was valued at USD 3.9 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 7% during the forecast period 2022 to 2028.

Breast cancer is characterized by the formation of malignant tumors in the breast cells that can spread to other parts of the body. Breast cancer is mainly observed in women. Breast cancer is diagnosed by doctors with the help of several tests to look for tumors where they started and that have spread to different parts of the body. Symptoms of breast cancer include lumps in the breast, changes in the shape of the breast, skin pits, fluid leakage from the nipples, and patches on the skin. Breast cancer can also develop in normal people due to several risk factors related to: Low physical exertion, drinking alcohol, obesity, menopause, family history, and childbirth at an older age. Breast cancer can be diagnosed early with certain screening tests, such as yearly mammograms, CT scans, and MRIs.

Market Segments

By Type

• Imaging
• Biopsy
• Genomic Tests
• Blood Tests
• Others

By Technology

• Fluorescent in Situ Hybridization (FISH)
• Comparative Genomic Hybridization (CGH)
• Immunohistochemical (IHC)
• Other Technologies

By Cancer Type

• BRCA Breast Cancer
• ER & PR Breast Cancer
• HER 2 Breast Cancer
• EGFR Mutation Test Breast Cancer

Key Players

• Abbott Laboratories
• Myriad Genetics Inc
• Hologic Inc
• Koninklijke Philips N.V.
• Fujifilm Holdings Corporation
• GE Healthcare
• Thermo Fischer Scientific Inc
• Siemens AG
• NanoString Technologies Inc
• C. R. Bard Inc
• Gamma Medica Inc
• Aurora Imaging Technology Inc
• Dilion Technologies Inc
• Genomic Health

Scope of the Report

The research study analyzes the global Breast Cancer Diagnostic industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Breast Cancer Diagnostic Market Report

1. What was the Breast Cancer Diagnostic Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Breast Cancer Diagnostic Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Breast Cancer Diagnostic Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.